Expressionedits
3 known investors
ExpressionEdits builds a computational platform, the Genetic Syntax Engine, that uses AI and intron-based transgene design to improve protein expression for therapeutic applications. The company develops an internal pipeline of therapeutic proteins and works on gene therapy partnerships.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
DL
Dr. Liliana AntunesGroup Leader, RNA Technologies; Co-founder
Investors · 3
Companies House · registry record
View on Companies House ↗- Registered name
- EXPRESSIONEDITS LTD
- Company number
- 13517470
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 19 Jul 2021
- Registered office
- 3rd Floor 1 Ashley Road, Altrincham, Cheshire, WA14 2DT
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 26 Aug 2025 · next due 9 Sept 2026
Current officers · 6
- Oakwood Corporate Secretary Limited — corporate secretary, appointed 19 May 2022
- Paul Bolno — director, appointed 4 Nov 2024
- Allan Bradley — director, appointed 1 Jun 2022
- Michael Sidler — director, appointed 10 Apr 2024
- Oliver William Sims — director, appointed 10 Apr 2024
- Kärt Tomberg — director, appointed 19 Jul 2021
Source: Companies House public register · retrieved 8 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.